Advertisement

Topics

Kedrion Biopharma, Inc. Company Profile

08:17 EST 23rd February 2019 | BioPortfolio

Kedrion Biopharma is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Kedrion Biopharma Inc., the U.S. subsidiary of Kedrion Biopharma, is headquartered in Fort Lee, New Jersey. Kedrion Biopharma launched US operations in 2011, but the company’s international roots stretch back several decades in the production of blood and plasma-derived products. Kedrion Biopharma places a high value on the welfare of those who benefit from its products, as well as on the people and the communities it serves. Additional information about Kedrion Biopharma can be found at www.kedrion.com and www.kedrion.us.


News Articles [1163 Associated News Articles listed on BioPortfolio]

Kedrion Biopharma Renewed Its Commitment to Patients with Primary Immunodeficiences at ESID 2018

Kedrion Biopharma, an Italian company specializing in the production and distribution of plasma-derived medicinal products, has been strongly improving its presence in Portugal.Ke...

Hillstream BioPharma looks forward to pre-IND discussion with FDA in Q4

Hillstream BioPharma CEO Randy Milby sits down with Proactive Investors' Christine Corrado at the BIO Investor Forum in San Francisco. Hillsteam BioPharma is developing targeted cancer therapeutic...

Vitro Diagnostics/DBA Vitro Biopharma: Vitro Biopharma Receives ISO 9001 Certification

GOLDEN, CO / ACCESSWIRE / December 11, 2018 / Vitro Diagnostics, Inc. (OTCPK: VODG), dba Vitro Biopharma ('Vitro') one of the world's emerging biotechnology companies focused on Umbilical Cord Mes...

This Day That Year: Cue Biopharma

Shares of Cue Biopharma Inc. (CUE) are down nearly 74% from their 52-week high of $17.99 recorded on March 14, 2018.

How the US-Mexico trade deal could impact the biologics market

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lioneâs biopharma practice group, the provisional detail revealed from the US administrationâs proposed trade d...

Biopharma Market: An Inside Look

Survey results reveal how slow-motion trends are driving biopharma growth

REPORT: Biopharma Mfg. Capacity and Production

222 biopharma companies surveyed plus130 industry vendors and direct suppliers of materials

MedCity News launches biopharma-focused newsletter

The biotech century has arrived, and it’s consequently now more important than ever for us to highlight our coverage of

Drugs and Medications [9 Associated Drugs and Medications listed on BioPortfolio]

Alferon [hemispherx biopharma, inc]

NA

Yupelri [the ritedose corporation]

Yupelri (Revefenacin) Inhalation Solution 175 mcg/3 mL

Keveyis [strongbridge us inc.]

These highlights do not include all the information needed to use KEVEYIS safely and effectively. See full prescribing information for KEVEYIS. KEVEYIS (dichlorphenamide) tablets, for oral use Initial...

Macrilen [strongbridge u.s. inc]

These highlights do not include all the information needed to use MACRILEN safely and effectively. See full prescribing information for MACRILEN.MACRILEN (macimorelin) for oral solution Initial U.S. A...

Recombinate [baxter healthcare corporation]

RECOMBINATE [Antihemophilic Factor (Recombinant)]

PubMed Articles [3 Associated PubMed Articles listed on BioPortfolio]

Biopharma dealmaking in 2018.

Innovation in Regulatory Science Is Meeting Evolution of Clinical Evidence Generation.

At the turn of the century, the pharmaceutical industry began a transition toward a focus on oncology, rare diseases, and other areas of high unmet need that required a new, more complex approach to d...

Bicyclic bis-heteroaryl derivatives as inhibitors of the α-synuclein protein: a patent evaluation of WO2018138088A1.

Neurodegenerative diseases commonly present misfolding and aggregation of one or more proteins, including α-synuclein, β-amyloid and tau. Several research efforts have been made to develop therapeut...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes

ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and ...

A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries

The process of re-narrowing of a coronary artery following a revascularization procedure such as angioplasty, begins at the time of the procedure. Restenosis has long been considered a ma...

Companies [150 Associated Companies listed on BioPortfolio]

Kedrion Biopharma, Inc.

Kedrion Biopharma is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and pre...

Kedrion Biopharma Inc.

Kedrion is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing se...

KEDRION BIOPHARMACEUTICALS

Kedrion is a biotechnology company specializing in the development, production and distribution of plasmaderivatives. It was founded in 2001 following the rationalization and optimization of operation...

SAFE-BioPharma Association

SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

More Information about "Kedrion Biopharma, Inc." on BioPortfolio

We have published hundreds of Kedrion Biopharma, Inc. news stories on BioPortfolio along with dozens of Kedrion Biopharma, Inc. Clinical Trials and PubMed Articles about Kedrion Biopharma, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Kedrion Biopharma, Inc. Companies in our database. You can also find out about relevant Kedrion Biopharma, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record